Author pages are created from data sourced from our academic publisher partnerships and public sources.
A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation.
- J. Goodman, D. Winston, +7 authors D. Friedman
- The New England journal of medicine
- 26 March 1992
BACKGROUND AND METHODS Superficial and systemic fungal infections are a major problem among severely immunocompromised patients who undergo bone marrow transplantation. We performed a double-blind,… Expand
Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide.
- G. Santos, P. Tutschka, +7 authors H. Kaizer
- The New England journal of medicine
- 1 December 1983
Fifty-one patients with acute nonlymphocytic leukemia (16 with end-stage disease, 17 in second or third remission or in early relapse, and 18 in first remission) were given infusions of HLA-identical… Expand
Expression of a single gene, BCL-6, strongly predicts survival in patients with diffuse large B-cell lymphoma.
Diffuse large B-cell lymphoma (DLBCL) is characterized by a marked degree of morphologic and clinical heterogeneity. Establishment of parameters that can predict outcome could help to identify… Expand
Evaluation of pulmonary complications after bone marrow transplantation: the role of pretransplant pulmonary function tests.
- R. Ghalie, J. Szidon, L. Thompson, Y. Nawas, A. Dolce, H. Kaizer
- Bone marrow transplantation
- 1 October 1992
To determine whether an association exists between abnormal pulmonary function tests (PFT) before bone marrow transplantation (BMT) and the rate of pulmonary complications after BMT, we… Expand
Novel insights into the biology of myelodysplastic syndromes: excessive apoptosis and the role of cytokines.
- A. Raza, S. Mundle, +17 authors S. Gregory
- Biology, Medicine
- International journal of hematology
- 1 June 1996
The paradox of myelodysplastic syndromes (MDS) which present with pancytopenias despite cellular bone marrows (BM) was investigated by conducting detailed studies of proliferation and apoptosis in 89… Expand
A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow…
Intravenous immunoglobulin is approved for use in allogeneic bone marrow transplant recipients for prevention of graft-versus-host disease (GVHD) and infections, but the minimally effective dose has… Expand
Autologous bone marrow transplantation in acute leukemia: a phase I study of in vitro treatment of marrow with 4-hydroperoxycyclophosphamide to purge tumor cells.
This phase I study was conducted to determine the maximal safe concentration of 4-hydroperoxycyclophosphamide (4HC) that could be used for in vitro treatment of bone marrow from patients with acute… Expand
Preliminary results of high-dose busulfan and cyclophosphamide with syngeneic or autologous bone marrow rescue.
- C. Lu, H. Braine, H. Kaizer, R. Saral, P. Tutschka, G. Santos
- Cancer treatment reports
- 1 May 1984
The toxic effects of high-dose busulfan (16 mg/kg) and cyclophosphamide (200 mg/kg) with autologous or syngeneic bone marrow rescue were evaluated in 19 patients (11 with acute myelocytic leukemia,… Expand
Evaluation of an architecture for intelligent query and exploration of time-oriented clinical data
- S. B. Martins, Yuval Shahar, +5 authors M. Goldstein
- Computer Science, Medicine
- Artif. Intell. Medicine
- 1 May 2008
A two-phase, balanced cross-over study to compare efficiency and satisfaction of a group of clinicians when answering queries of variable complexity about time-oriented clinical data, typical for oncology protocols, using KNAVE-II, versus standard methods: both paper charts and a popular electronic spreadsheet. Expand
Prevention of hypermenorrhea with leuprolide in premenopausal women undergoing bone marrow transplantation
- R. Ghalie, C. Porter, E. Radwanska, W. Fitzsimmons, C. Richman, H. Kaizer
- American journal of hematology
- 1 April 1993
We report on the use of leuprolide to prevent heavy menstrual bleeding that often occurs before platelet engraftment in premenopausal women undergoing bone marrow transplantation (BMT). Leuprolide, a… Expand